| Part Of FDA Advisory Committee Unanimously Approves Johnson & Johnson COVID-19 Vaccine

FDA Open Meeting on Johnson & Johnson COVID-19 Vaccine, Part 1

The Food and Drug Administration (FDA) held a virtual open meeting to discuss emergency use authorization for the Johnson & Johnson… read more

The Food and Drug Administration (FDA) held a virtual open meeting to discuss emergency use authorization for the Johnson & Johnson COVID-19 vaccine. After a roll call of advisory board members, the FDA outlined the reason for emergency use authorization for this vaccine created by Janssen Biotech, which is the pharmaceutical division of Johnson & Johnson. The advisory board took a brief break to address technical difficulties. This was the first portion of the daylong advisory board hearing. close

Report Video Issue

People in this video

  • Maria Allende Clinical Review Chief U.S. Food and Drug Administration->Vaccines and Related Products
  • Paula Annunziato Associate Vice President Merck Research Laboratories
  • Prabhakara Atreya Director U.S. Food and Drug Administration->Scientific Advisers and Consultants
  • Archana Chatterjee Senior Associate Dean University of South Dakota->Medical School
  • Amanda Cohn Executive Secretary Advisory Committee on Immunization Practices
  • Oveta Fuller Professor University of Michigan Medical School
  • Hayley Gans Professor Stanford University->Pediatric Infectious Diseases
  • Marion Gruber Director U.S. Food and Drug Administration->Office of Vaccine Research and Review
  • James Hildreth M.D. President and CEO Meharry Medical College
  • Mike Kaczynski Project Manager U.S. Food and Drug Administration
  • David Kim Director Centers for Disease Control and Prevention->Immunization Division
  • Michael Kurilla Director National Institutes of Health->Division of Clinical Innovation
  • Jeannette Lee Professor University of Arkansas->Biostatistics
  • Ofer Levy Director Boston Children's Hospital->Precision Vaccines Program
  • Peter W. Marks M.D. Deputy Director U.S. Food and Drug Administration->Center for Biologics Evaluation and Research
  • Pamela McInnes Director National Institutes of Health->National Center for Advancing Translational Sciences
  • Cody Meissner Professor Tufts University->Infectious Diseases
  • Arnold Monto Professor University of Michigan->Epidemiology
  • Patrick Moore Professor University of Pittsburgh->Cancer Institute
  • Paul Offit M.D. Chief Children's Hospital of Philadelphia->Division of Infectious Diseases
  • Steven Pergam Professor Fred Hutchinson Cancer Research Center
  • Stanley Perlman Professor University of Iowa->Immunology
  • Jay Portnoy Professor Children's Mercy Hospital->Pediatrics
  • Eric Rubin Editor in Chief New England Journal of Medicine
  • Mark Sawyer M.D. Specialist Rady Children's Hospital->Infectious Diseases
  • Melinda Wharton Director Centers for Disease Control and Prevention->Immunization Division
More People

Hosting Organization

More Videos From

FDA Advisory Committee Unanimously Approves Johnson & Johnson COVID-19 Vaccine

More Videos
More information about

FDA Open Meeting on Johnson & Johnson COVID-19 Vaccine, Part 1

1,215 Views
Program ID:
509043-2
Category:
Public Affairs Event
Format:
Meeting
Location:
Washington, District of Columbia, United States
First Aired:
Feb 26, 2021 | 9:01am EST | C-SPAN 2
Last Aired:
Feb 27, 2021 | 6:52am EST | C-SPAN 2

Airing Details

  • Feb 26, 2021 | 9:01am EST | C-SPAN 2
  • Feb 26, 2021 | 9:00pm EST | C-SPAN 2
  • Feb 27, 2021 | 6:52am EST | C-SPAN 2